SEC Form 4 · accession 0001209191-15-072859
NEUROCRINE BIOSCIENCES INC · NBIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George J Morrow
Director
Period of report
Sep 30, 2015
Accepted (ET)
Oct 1, 2015 · 7:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000914475
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $39.79 | Sep 30, 2015 | A | 40,000 | A | Oct 30, 2015 | Sep 29, 2025 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1Option granted September 30, 2015 and vests in 36 equal monthly installments.